Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis).

Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis). BMC Cancer. 2021 Apr 06; 21(1):358.

View in: PubMed

subject areas

Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Doxorubicin
Febrile Neutropenia
Female
Granulocyte Colony-Stimulating Factor
Humans
Lymphoma, Non-Hodgkin
Male
Middle Aged
Prednisone
Retrospective Studies
Rituximab
Vincristine

authors with profiles

Yuko Mishima